Therapeutic Grand Rounds
Date: 23/10/2024 (AEDT)
Venue: 323 Nepean Highway, Brighton East, VIC, 3187
Provider: Bayside Eye Specialists
Contact: Lara Sullivan, [E] lara@baysideeyes.com.au, [P] 0438544799
Activity Outline
Therapeutic Grand Rounds
Dr Wen Lim, a fellowship trained medical retinal specialist and cataract surgeon will discuss the different intravitreal drugs used for retinal diseases and infectious diseases in the eye.
Dr Colby Hart will focus on the considerations for patients who require cataract surgery while also suffering from corneal pathology. His presentation will highlight the therapeutic options used to optimise patients prior to cataract surgery with an emphasis on the role that optometrists can play in this setting.
Dr Helen Garrott will discuss assessment of eyelid lesions in patients, using case studies to demonstrate potential treatment options including the use of topical agents for premalignant and malignant skin lesions.
Learning Objectives
- Understand the different intravitreal drugs used for retinal diseases and their clinical indications
- Understand the risks and side effects of certain intravitreal drugs
- Understand infectious diseases in the eye and when intravitreal therapy is indicated
- To be able to recognise the clinical signs of corneal pathology in patients and understand how these will impact the timing and management of their cataract
- To understand the therapeutic options that exist for optimising patients with corneal disease prior to having cataract surgery
- To appreciate when early referral of patients to an ophthalmologist may help to improve long-term visual outcomes when suffering from multiple pathologies
- To develop therapeutic solutions for managing patients who suffer from corneal pathology following their cataract surgery, and when to refer back to an ophthalmologist
- Review of basic eyelid anatomy
- Diagnose common eyelid lumps
- Recognise red flag signs which should prompt urgent referral
- Distinguish benign from malignant eyelid lesions
- Consider treatment options including surgery or topical agents such as 5FU
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| Intravitreal Drugs |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Cataract surgery in patients with corneal disease - therapeutic options to optimise success |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Assessment of eyelid lesions - case studies and topical agents |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |